ArticleDiagnostics (Basel, Switzerland)2023
A Novel Multi-Task Learning Network Based on Melanoma Segmentation and Classification with Skin Lesion Images.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Diagnosis melanoma with artificial intelligence systems: A meta-analysis study and systematic review.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025Pooled it
- Artificial intelligence with deep learning driven entropy-curvature attention mechanism for detection and segmentation of skin lesions using biomedical images.Scientific reports · 2026Article
- Hydrogel-based delivery systems for cutaneous melanoma therapy: from chemical design and crosslinking strategies to structure-activity relationships.RSC advances · 2026Review
- Early-Stage Melanoma Benchmark Dataset.Cancers · 2025Article
- Addressing Challenges in Skin Cancer Diagnosis: A Convolutional Swin Transformer Approach.Journal of imaging informatics in medicine · 2025Article
- Precision and efficiency in skin cancer segmentation through a dual encoder deep learning model.Scientific reports · 2025Article
- Skin Cancer Image Classification Using Artificial Intelligence Strategies: A Systematic Review.Journal of imaging · 2024Review
- LesionNet: an automated approach for skin lesion classification using SIFT features with customized convolutional neural network.Frontiers in medicine · 2024Article
- SkinNet-INIO: Multiclass Skin Lesion Localization and Classification Using Fusion-Assisted Deep Neural Networks and Improved Nature-Inspired Optimization Algorithm.Diagnostics (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Melanoma is known worldwide as a malignant tumor and the fastest-growing skin cancer type. It is a very life-threatening disease with a high mortality rate. Automatic melanoma detection improves the early detection of the disease and the survival rate. In accordance with this purpose, we presented a multi-task learning approach based on melanoma recognition with dermoscopy images. Firstly, an effective pre-processing approach based on max pooling, contrast, and shape filters is used to eliminate hair details and to perform image enhancement operations. Next, the lesion region was segmented with a VGGNet model-based FCN Layer architecture using enhanced images. Later, a cropping process was performed for the detected lesions. Then, the cropped images were converted to the input size of the classifier model using the very deep super-resolution neural network approach, and the decrease in image resolution was minimized. Finally, a deep learning network approach based on pre-trained convolutional neural networks was developed for melanoma classification. We used the International Skin Imaging Collaboration, a publicly available dermoscopic skin lesion dataset in experimental studies. While the performance measures of accuracy, specificity, precision, and sensitivity, obtained for segmentation of the lesion region, were produced at rates of 96.99%, 92.53%, 97.65%, and 98.41%, respectively, the performance measures achieved rates for classification of 97.73%, 99.83%, 99.83%, and 95.67%, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.